Immune Dysfunction in Autism Spectrum Disorders

Molecular and Integrative Toxicology

Volumn , Issue , 2012, Pages 253-269

  Careaga, Milo ^a,b   Van de Water, Judy ^c   Ashwood, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism Spectrum Disorder; Broad Autism Phenotype; Celiac Disease; Immune Dysfunction; Natural Killer Cell

Indexed keywords

EID: 84871670055     PISSN: 21684219     EISSN: 21684235     Source Type: Book Series    
DOI: 10.1007/978-1-61779-812-2_10     Document Type: Chapter

References (122)

1. Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F et al (2010) Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68(12):1172–1181. doi:10.1016/j.biopsych.2010.09.022
2. Adams J, Johansen L, Powell L, Quiq D, Rubin R (2011) Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to neurotypical children and correlation with autism severity. BMC Gastroenterol 11(1):22
3. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M et al (2009) IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol 29(1):130–136. doi:10.1007/s10875-008-9229-9
4. Ashwood P, Wakefield AJ (2006) Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173(1–2):126–134. doi:S0165-5728(05)00539-4[pii]10.1016/j.jneuroim.2005.12.007
5. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23(6):504–517. doi:474304[pii]
6. Ashwood P, Anthony A, Torrente F, Wakefield AJ (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24(6):664–673. doi:10.1007/s10875-004-6241-6
7. Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA et al (2008) Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204(1–2):149– 153. doi:S0165-5728(08)00293-2[pii]10.1016/j.jneuroim.2008.07.006
8. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011a) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25(1):40–45. doi:10.1016/j.bbi.2010.08.003
9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011b) Altered T cell responses in children with autism. Brain Behav Immun 25(5):840–849. doi:S0889-1591(10)00460-5[pii]10.1016/j.bbi.2010.09.002
10. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011c) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232(1–2):196–199
11. Atladottir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton WW et al (2009) Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124(2):687–694. doi:peds.2008-2445[pii]10.1542/peds.2008-2445
12. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M et al (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40(12):1423–1430. doi:10.1007/s10803-010-1006-y
13. Borrell J, Vela JM, Arevalo-Martin A, Molina-Holgado E, Guaza C (2002) Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26(2):204–215. doi:S0893133X01003608[pii]10.1 016/S0893-133X(01)00360-8
14. Braunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA et al (2008) Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29(2):226–231. doi:S0161-813X(07)00244-6[pii]10.1016/j.neuro.2007.10.010
15. Buie T, Campbell DB, Fuchs GJ III, Furuta GT, Levy J, Vandewater J et al (2010) Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(suppl 1):S1–S18. doi:125/Supplement_1/S1[pii]10.1542/peds.2009-1878C
16. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S et al (2006) A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 103(45):16834–16839. doi:0605296103[pii]10.1073/pnas.0605296103
17. Careaga M, Van de Water J, Ashwood P (2010) Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 7(3):283–292. doi:S1933-7213(10)00045-0[pii]10.1016/j.nurt.2010.05.003
18. Chess S (1977) Follow-up report on autism in congenital rubella. J Autism Child Schizophr 7(1):69–81
19. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14(6):388–394
20. Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM et al (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59(4):354–363. doi:S0006-3223(05)00851-6[pii]10.1016/j.biopsych.2005.07.004
21. Constantino JN, Zhang Y, Frazier T, Abbacchi AM, Law P (2010) Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 167(11):1349–1356. doi:appi.ajp. 2010.09101470[pii]10.1176/appi.ajp.2010.09101470
22. Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33(3–4):197–207. doi:S0896-8411(09)00122-X[pii]10.1016/j.jaut.2009.09.008
23. Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P et al (2007) A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 12(3):292–306. doi:4001943[pii]10.1038/sj.mp.4001943
24. Correll PH, Morrison AC, Lutz MA (2004) Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol 75(5):731–737. doi:10.1189/jlb.0703347
25. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J (2005) Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 159(2):151–157. doi:159/2/151[pii]10.1001/archpedi.159.2.151
26. Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E et al (2002) Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32(8):1457–1463
27. D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M et al (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr 85(9):1076–1079
28. Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL et al (1995) Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 32(3):120–123
29. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46– 56. doi:nrn2297[pii]10.1038/nrn2297
30. de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P et al (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51(4):418–424. doi:10.1097/MPG.0b013e3181dcc4a5
31. Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64(1):61–78. doi:S0896-6273(09)00680-1[pii]10.1016/j.neuron.2009.09.002
32. Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB (2010) Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 12(6):638–646. doi:10.1111/j.1399-5618.2010.00853.x
33. Ehninger D, Sano Y, de Vries PJ, Dies K, Franz D, Geschwind DH et al (2012) Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry 17(1):62–70. doi:mp2010115[pii]10.1038/mp. 2010.115
34. Enstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, Hansen RL et al (2009a) Increased IgG4 levels in children with autism disorder. Brain Behav Immun 23(3):389–395. doi:S0889-1591(08)00455-8[pii]10.1016/j.bbi.2008.12.005
35. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN et al (2009b) Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 23(1):124–133. doi:S0889-1591(08)00317-6[pii]10.1016/j.bbi.2008.08.001
36. Enstrom AM, Van de Water JA, Ashwood P (2009c) Autoimmunity in autism. Curr Opin Investig Drugs 10(5):463–473
37. Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24(1):64–71. doi:S0889-1591(09)00388-2[pii]10.1016/j.bbi.2009.08.001
38. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM et al (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4(4):e1000024. doi:10.1371/journal.pgen.1000024
39. Fu J, Jiang Y, Liang L, Zhu H (2005) Risk factors of primary thyroid dysfunction in early infants born to mothers with autoimmune thyroid disease. Acta Paediatr 94(8):1043–1048
40. Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA et al (2001) Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138(3):366–372. doi:S0022-3476(01)92227-9[pii]10.1067/mpd.2001.111323
41. Genuis SJ, Bouchard TP (2010) Celiac disease presenting as autism. J Child Neurol 25(1):114– 119. doi:0883073809336127[pii]10.1177/0883073809336127
42. Gilmore JH, Jarskog LF, Vadlamudi S (2005) Maternal poly I: C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 159(1–2):106–112. doi:S0165-5728(04)00372-8[pii]10.1016/j.jneu-roim. 2004.10.008
43. Goines P, Van de Water J (2010) The immune system’s role in the biology of autism. Curr Opin Neurol 23(2):111–117. doi:110.1097/WCO.1090b1013e3283373514
44. Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L et al (2011) Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 25(3):514–523. doi:S0889-1591(10)00572-6[pii]10.1016/j.bbi.2010.11.017
45. Grigorenko EL, Han SS, Yrigollen CM, Leng L, Mizue Y, Anderson GM et al (2008) Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122(2):e438–e445. doi:122/2/e438[pii]10.1542/peds.2007-3604
46. Guerini FR, Bolognesi E, Manca S, Sotgiu S, Zanzottera M, Agliardi C et al (2009) Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders. Hum Immunol 70(3):184–190. doi:S0198-8859(09)00004-4[pii]10.1016/j.humimm.2008.12.009
47. Gupta S, Aggarwal S, Rashanravan B, Lee T (1998) Th1-and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85(1):106–109. doi:S0165-5728(98)00021-6[pii]
48. Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A (2007) Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly. Am J Med Genet A 143(6):589–593. doi:10.1002/ajmg.a.31619
49. Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz-Picciotto I et al (2008) Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 1(5):275–283. doi:10.1002/aur.42
50. Hsiao EY, Patterson PH (2011) Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 25(4):604–615. doi:S0889-1591(10)00590-8[pii]10.1016/j.bbi.2010.12.017
51. Jyonouchi H, Sun S, Le H (2001) Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120(1–2):170–179. doi:S0165572801004210[pii]
52. Jyonouchi H, Sun S, Itokazu N (2002) Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46(2):76–84. doi:nps46076[pii]
53. Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H (2008) Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation 5:52. doi:1742-2094-5-52[pii]10.1186/1742-2094-5-52
54. Kanner L (1968) Autistic disturbances of affective contact. Acta Paedopsychiatr 35(4):100–136
55. Keil A, Daniels JL, Forssen U, Hultman C, Cnattingius S, Soderberg KC et al (2010) Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology 21(6):805–808. doi:10.1097/EDE.0b013e3181f26e3f
56. Kirkman NJ, Libbey JE, Sweeten TL, Coon HH, Miller JN, Stevenson EK et al (2008) How relevant are GFAP autoantibodies in autism and Tourette syndrome? J Autism Dev Disord 38(2):333–341. doi:10.1007/s10803-007-0398-9
57. Klauck SM, Poustka A (2006) Animal models of autism. Drug Discov Today Dis Models 3(4):313– 318. doi:10.1016/j.ddmod.2006.11.005
58. Lasala N, Zhou H (2007) Effects of maternal exposure to LPS on the inflammatory response in the offspring. J Neuroimmunol 189(1–2):95–101. doi:S0165-5728(07)00252-4[pii]10.1016/j. jneuroim.2007.07.010
59. Lee LC, Zachary AA, Leffell MS, Newschaffer CJ, Matteson KJ, Tyler JD et al (2006) HLA-DR4 in families with autism. Pediatr Neurol 35(5):303–307. doi:S0887-8994(06)00383-3[pii]10.1016/j.pediatrneurol.2006.06.006
60. Lee JY, Huerta PT, Zhang J, Kowal C, Bertini E, Volpe BT et al (2009) Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 15(1):91–96. doi:nm.1892[pii]10.1038/nm.1892
61. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li X-M et al (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207(1–2):111–116. doi:10.1016/j. jneuroim.2008.12.002
62. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS (2005) Autistic disorder and viral infections. J Neurovirol 11(1):1–10. doi:NJ68871176460170[pii]10.1080/13550280590900553
63. Libbey JE, Coon HH, Kirkman NJ, Sweeten TL, Miller JN, Stevenson EK et al (2008) Are there enhanced MBP autoantibodies in autism? J Autism Dev Disord 38(2):324–332. doi:10.1007/s10803-007-0400-6
64. Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C et al (2009) Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol Psychiatry 14(7):705–718. doi:mp200821[pii]10.1038/mp. 2008.21
65. Mandal M, Marzouk AC, Donnelly R, Ponzio NM (2010) Preferential development of Th17 cells in offspring of immunostimulated pregnant mice [research support, Non-U.S. Gov’t]. J Reprod Immunol 87(1–2):97–100. doi:10.1016/j.jri.2010.06.156
66. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG (2008) Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 22(6):806–816. doi:S0889-1591(07)00340-6[pii]10.1016/j. bbi.2007.12.007
67. McAllister DL, Kaplan BJ, Edworthy SM, Martin L, Crawford SG, Ramsey-Goldman R et al (1997) The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. J Int Neuropsychol Soc 3(4):370–376
68. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008) Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22(4):469–486. doi:S0889-1591(07)00255-3[pii]10.1016/j.bbi.2007.09.012
69. Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, Dunn M et al (2006) Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: a CPEA Study. J Autism Dev Disord 36(3):317–324. doi:10.1007/s10803-005-0071-0
70. Money J, Bobrow NA, Clarke FC (1971) Autism and autoimmune disease: a family study. J Autism Child Schizophr 1(2):146–160
71. Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63(6):425–433. doi:AJI836[pii]10.1111/j.1600-0897.2010.00836.x
72. Morris CM, Zimmerman AW, Singer HS (2009) Childhood serum anti-fetal brain antibodies do not predict autism. Pediatr Neurol 41(4):288–290. doi:S0887-8994(09)00212-4[pii]10.1016/j. pediatrneurol.2009.04.014
73. Mouridsen SE, Rich B, Isager T, Nedergaard NJ (2007) Autoimmune diseases in parents of children with infantile autism: a case-control study. Dev Med Child Neurol 49(6):429–432. doi:DMCN429[pii]10.1111/j.1469-8749.2007.00429.x
74. Murphy TK, Kurlan R, Leckman J (2010) The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 20(4):317–331. doi:10.1089/cap.2010.0043
75. Neri F, Chimini L, Bonomi F, Filippini E, Motta M, Faden D et al (2004) Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 13(10):805–811
76. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H et al (2005) Confirmation of the association of the C4B null allele in autism. Hum Immunol 66(2):140–145. doi:S0198-8859(04)00680-9[pii]10.1016/j.humimm.2004.11.002
77. Okada K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ et al (2007) Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 31(1):187–190. doi:S0278-5846(06)00339-3[pii]10.1016/j.pnpbp.2006.08.020
78. Plioplys AV, Greaves A, Kazemi K, Silverman E (1994) Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29(1):12–16
79. Qaqish BF, Prisayanh P, Qian Y, Andraca E, Li N, Aoki V et al (2009) Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol 129(1):110–118. doi:jid2008189[pii]10.1038/jid.2008.189
80. Rolim A, Castro M, Santiago M (2006) Neonatal antiphospholipid syndrome. Lupus 15(5):301
81. Rosen NJ, Yoshida CK, Croen LA (2007) Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 119(1):e61–e69. doi:119/1/e61[pii]10.1542/peds.2006-1788
82. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML et al (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15(7):429–435
83. Saresella M, Marventano I, Guerini FR, Mancuso R, Ceresa L, Zanzottera M et al (2009) An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 66(10):978–984. doi:S0006-3223(09)00825-7[pii]10.1016/j.biopsych.2009.06.020
84. Schwartz M, Kipnis J (2011) A conceptual revolution in the relationships between the brain and immunity. Brain Behav Immun 25(5):817–819. doi:S0889-1591(10)00588-X[pii]10.1016/j. bbi.2010.12.015
85. Serajee FJ, Zhong H, Mahbubul Huq AH (2006) Association of Reelin gene polymorphisms with autism. Genomics 87(1):75–83. doi:S0888-7543(05)00256-9[pii]10.1016/j.ygeno.2005.09.008
86. Silva SC, Correia C, Fesel C, Barreto M, Coutinho AM, Marques C et al (2004) Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunol 152(1–2):176–182. doi:10.1016/j.jneuroim.2004.03.015S0165572804001213[pii]
87. Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 18(1):41–78. doi:10.1089/vim.2005.18.41
88. Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M (2009) Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J Neuroimmunol 211(1–2):39–48. doi:S0165-5728(09)00105-2[pii]10.1016/j.jneuroim.2009.03.011
89. Singh VK (1996) Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 66(1–2):143–145. doi:10.1016/0165-5728(96)00014-8
90. Singh VK, Warren RP, Odell JD, Cole P (1991) Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol 61(3):448–455
91. Singh VK, Warren RP, Odell JD, Warren WL, Cole P (1993) Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 7(1):97–103. doi:S0889-1591(83)71010-X[pii]10.1006/brbi.1993.1010
92. Singh VK, Warren R, Averett R, Ghaziuddin M (1997) Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17(1):88–90. doi:S0887899497000453[pii]
93. Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER et al (2005) Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry 10(6):563–571. doi:4001614[pii]10.1038/sj.mp. 4001614
94. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27(40):10695–10702. doi:27/40/10695[pii]10.1523/ JNEUROSCI.2178-07.2007
95. Smith SEP, Hsiao E, Patterson PH (2010) Activation of the maternal immune system as a risk factor for neuropsychiatric disorders. In: Zimmerman AW, Connors SL (eds) Maternal influences on fetal neurodevelopment. Springer, New York, pp 97–115
96. Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27(2):71–80. doi:S0896-8411(06)00071-0[pii]10.1016/j.jaut.2006.07.006
97. Stubbs EG (1976) Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 6(3):269–274
98. Stubbs EG, Magenis RE (1980) HLA and autism. J Autism Dev Disord 10(1):15–19
99. Surriga O, Ortega A, Jadeja V, Bellafronte A, Lasala N, Zhou H (2009) Altered hepatic inflammatory response in the offspring following prenatal LPS exposure. Immunol Lett 123(1):88–95. doi:S0165-2478(09)00057-1[pii]10.1016/j.imlet.2009.02.009
100. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ (2003a) Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112(5):e420
101. Sweeten TL, Posey DJ, McDougle CJ (2003b) High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160(9):1691–1693
102. Sweeten TL, Posey DJ, McDougle CJ (2004) Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34(5):583–586
103. Tincani A, Rebaioli CB, Frassi M, Taglietti M, Gorla R, Cavazzana I et al (2005) Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev 4(7):423–428. doi:S1568-9972(05)00037-6[pii]10.1016/j.autrev.2005.03.001
104. Tincani A, Danieli E, Nuzzo M, Scarsil M, Motta M, Cimaz R et al (2006) Impact of in utero environment on the offspring of lupus patients. Lupus 15(11):801–807
105. Todd RD, Ciaranello RD (1985) Demonstration of inter-and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci USA 82(2):612–616
106. Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A et al (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7(4):375–382, 334. doi:10.1038/sj.mp.4001077
107. Torrente F, Anthony A, Heuschkel RB, Thomson MA, Ashwood P, Murch SH (2004) Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Helicobacter pylori gastritis. Am J Gastroenterol 99(4):598–605. doi:10.1111/j.1572-0241.2004.04142. xAJG4142[pii]
108. Torres AR, Maciulis A, Stubbs EG, Cutler A, Odell D (2002) The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol 63(4):311–316. doi:S0198885902003749[pii]
109. Valicenti-McDermott MD, McVicar K, Cohen HJ, Wershil BK, Shinnar S (2008) Gastrointestinal symptoms in children with an autism spectrum disorder and language regression. Pediatr Neurol 39(6):392–398. doi:S0887-8994(08)00351-2[pii]10.1016/j.pediatrneurol.2008.07.019
110. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57(1):67–81. doi:10.1002/ana.20315
111. Vojdani A, O’Bryan T, Green JA, McCandless J, Woeller KN, Vojdani E et al (2004) Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 7(3):151–161
112. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K et al (2008) Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol 205(1–2):148–154. doi:S0165-5728(08)00398-6[pii]10.1016/j.jneuroim.2008.09.005
113. Warren RP, Margaretten NC, Pace NC, Foster A (1986) Immune abnormalities in patients with autism. J Autism Dev Disord 16(2):189–197
114. Warren RP, Foster A, Margaretten NC (1987) Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26(3):333–335. doi:S0890-8567(09)65685-9[pii]10.1097/00004583-198705000-00008
115. Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL et al (1992) Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 36(4):203–207
116. Warren RP, Burger RA, Odell D, Torres AR, Warren WL (1994) Decreased plasma concentrations of the C4B complement protein in autism. Arch Pediatr Adolesc Med 148(2):180–183
117. Warren RP, Yonk J, Burger RW, Odell D, Warren WL (1995) DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31(2):53–57
118. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW et al (1997) Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord 27(2):187–192
119. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J (2007) Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci 1107:79–91. doi:1107/1/79[pii]10.1196/ annals.1381.009
120. Wiznitzer M (2004) Autism and tuberous sclerosis. J Child Neurol 19(9):675–679
121. Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR et al (2002) Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 7(9):1012–1017. doi:10.1038/sj. mp. 4001124
122. Zimmerman AW, Connors SL, Matteson KJ, Lee LC, Singer HS, Castaneda JA et al (2007) Maternal antibrain antibodies in autism. Brain Behav Immun 21(3):351–357. doi:S0889-1591(06)00294-7[pii]10.1016/j.bbi.2006.08.005